Maple-Brown Abbott Asian Dividend Growth Fund
The Fund is an actively managed fund that invests in listed (and to be listed) securities across Asia that we believe have sustainable and growing income streams and the potential for long-term capital growth.
We believe one of the key identifiers of strong total returns of Asian equities is dividend growth. The Fund’s investment universe comprises companies across the Asian region with a market capitalisation typically above US$1 billion dollars. To narrow the investment universe, we apply two distinct quantitative screening models to identify those companies with both the ability to pay a sustainable and attractive dividend stream, and the intention to reward shareholders with an attractive dividend profile going forward. The quantitative screens are complemented by bottom-up fundamental research, where we conduct detailed quantitative and qualitative analysis on select companies that have been identified from the two quantitative screens. This in-depth research includes detailed financial forecasts, meetings with company management and an assessment of management quality, industry structure and ESG factors. The Fund typically holds between 25–40 stocks.
The Fund aims to deliver an attractive total return, after fees, over a five-year period whilst maintaining a dividend yield in excess of the MSCI All Countries Asia excluding Japan Net Index (AUD).
|Inception date23/06/2021||Distribution frequencySemi-annually|
|BenchmarkMSCI All Countries Asia excluding Japan Net Index (AUD)||Minimum initial application$ 20,000|
|APIR codeMPL8237AU||Management costs %0.90|
|Pricing frequency & cut-offDaily/2pm Sydney time on a Business Day||Buy/Sell spread %0.28/0.28|
Head of Asia Pacific Equities
Investment Analyst, Asian Equities
as at 31/05/2022
|1 mth %||3 mths %||Since inception %|
^Past performance is not a reliable indicator of future performance. No warranty can be given for future performance. Returns are volatile and may fluctuate quickly and significantly. Total return is based on the movement in net asset value per unit plus distributions and is before tax and after all fees and charges. Imputation and foreign tax credits are not included in the performance figures. Source: Maple-Brown Abbott and MSCI
* Inception date is 23 June 2021.
The MSCI information may not be reproduced or redisseminated in any form and may not be used as a basis for or a component of any financial instruments or products or indices. None of the MSCI information is intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such. Historical data and analysis should not be taken as an indication or guarantee of any future performance analysis, forecast or prediction. The MSCI information is provided on an “as is” basis and the user of this information assumes the entire risk of any use made of this information. MSCI, each of its affiliates and each other person involved in or related to compiling, computing or creating any MSCI information (collectively, the “MSCI Parties”) expressly disclaims all warranties (including, without limitation, any warranties of originality, accuracy, completeness, timeliness, non-infringement merchantability and fitness for a particular purpose) with respect to this information. Without limiting any of the foregoing, in no event shall any MSCI Party have any liability for any direct, indirect, special, incidental, punitive, consequential (including, without limitation, lost profits) or any other damages. (www.msci.com)
as at 30/06/2022
|Redemption price||Net asset value||Application price|
|$ 0.9935||$ 0.9963||$ 0.9991|
Interested in investing with us?